Skip to main content
Glama

Bcb Br

by io.github.pipeworx-io

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
-  "company"
-]New value: +[
+  "company",
+  "ticker"
+]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. First observed

TDQS

A4.8/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint=true and idempotentHint=true, and the description goes well beyond them: it discloses fan-out behavior across sources, soft-fail behavior for the USPTO API, that empty sections mean real 'no data', that FDA product absence is expected for small-molecule-only companies, and that private companies return resolved:false with a notes line. This substantially helps the agent interpret results correctly.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long, but the tool is complex and has no output schema to rely on. It is dense with high-signal information and front-loads natural-language triggers and the 'ALWAYS PREFER' rule before enumerating return fields. A small amount of trimming is possible, but every sentence earns its place.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a tool with no output schema, the description is remarkably complete: it enumerates every returned section, explains failure modes, gives URI examples, and covers input normalization and private-company behavior. An agent has enough context to invoke it correctly and interpret the response without guessing.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so the baseline is 3. The description adds value by giving concrete examples ('AAPL', '0000320193', 'Moderna'), clarifying that type accepts either 'company' or 'ticker' interchangeably, and noting name resolution via SEC EDGAR. It mostly reinforces the schema but with useful examples and edge-case context.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description names a specific verb and resource: it builds a 'full cross-source profile of a US public company in ONE parallel call.' It also differentiates itself from chained single-pack SEC/XBRL/news lookups, making the tool's unique role clear relative to siblings.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description provides explicit trigger examples ('Tell me about X', 'research Acme', 'brief me on Tesla') and states 'ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view.' This gives the agent a clear selection rule and names the alternative approach.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Bcb Br toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A4.4/5.0
Disambiguation5/5

Each tool has a distinct purpose; even similar tools like ask_pipeworx and ask_pipeworx_grounded are clearly differentiated by grounding behavior. Polymarket tools are separated by specific angles (arbitrage, edges, tracking, fill risk, cross-venue).

Naming Consistency5/5

All tool names use consistent snake_case with descriptive verbs (ask_, compare_, discover_, generate_, list_, recall_, etc.). No mixing of camelCase or other conventions.

Tool Count4/5

35 tools is on the higher end but justified by the breadth of functionality: Brazilian economics, Pipeworx data querying, company analysis, Polymarket betting, memory, subscriptions, etc. Each tool seems necessary, though a few could potentially be consolidated.

Completeness4/5

The tool set covers major CRUD operations and data retrieval across multiple domains. Minor gaps exist (e.g., no tool to edit subscriptions directly, but unsubscribe/resubscribe works). Overall, the surface is well-rounded for the stated purposes.

Resources